CytoMed Therapeutics Limited's market cap is currently ―. The company's EPS TTM is $-0.267; its P/E ratio is -8.45; CytoMed Therapeutics Limited is scheduled to report earnings on November 17, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Dec 21
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	S$ 9.04M	S$ 1.42M	S$ 1.49M	S$ 2.51M
Total Assets	S$ 12.37M	S$ 8.22M	S$ 5.15M	S$ 6.08M
Total Debt	S$ 448.02K	S$ 483.25K	S$ 3.36M	S$ 3.26M
Net Debt	S$ -8.59M	S$ -934.72K	S$ 1.87M	S$ 745.93K
Total Liabilities	S$ 1.12M	S$ 7.69M	S$ 3.59M	S$ 3.49M
Stockholders Equity	S$ 11.25M	S$ -6.12M	S$ 1.56M	S$ 2.59M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in SGD

CytoMed Therapeutics Limited Earnings and Revenue History

Income Statement >

CytoMed Therapeutics Limited Debt to Assets

Balance Sheet >

CytoMed Therapeutics Limited Cash Flow

Cash Flow >

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing